The Ability of Serum Amyloid A to Discriminate Coronavirus Disease 2019 ( <scp>COVID</scp> ‐19) Patients Who Stay Moderately Ill Versus Patients Who Become Severely Ill
Our study demonstrates that SAA, CRP, ferritin, and PCT levels at the time of hospitalization failed to discriminate between COVID-19 patients who remain moderately ill and those who progress to severe disease within 7 days.
Authors
- Simone P. Rauh (ORCID: https://orcid.org/0000-0003-3627-6925)
- Nadine Pouw (ORCID: https://orcid.org/0000-0002-6470-3720)
- Erwin Birnie (ORCID: https://orcid.org/0000-0002-4534-4857)
- Gert‐Jan Braunstahl (ORCID: https://orcid.org/0000-0001-7671-3742)
- Tessa Noordermeer (ORCID: https://orcid.org/0000-0003-2929-4930)
- B. M. Boxma-de Klerk
- Sander Mol
- Evert‐Jan Wils
- Ellen M. van der Zwan‐van Beek
Institutions
- University Medical Center Groningen (NL)
- Leiden University Medical Center (NL)
- Sint Franciscus Gasthuis (NL)
- Franciscus Vlietland (NL)
Publication Details
- Journal
- Journal of Clinical Laboratory Analysis
- Published
- 2026-03-16
- DOI
- https://doi.org/10.1002/jcla.70193
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00